BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21672358)

  • 1. Cyclin-dependent kinase-associated protein Cks2 is associated with bladder cancer progression.
    Chen R; Feng C; Xu Y
    J Int Med Res; 2011; 39(2):533-40. PubMed ID: 21672358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer.
    Mezzasoma L; Antognelli C; Del Buono C; Stracci F; Cottini E; Cochetti G; Talesa VN; Mearini E
    BMC Urol; 2010 Oct; 10():17. PubMed ID: 20920335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.
    Tanaka F; Matsuzaki S; Mimori K; Kita Y; Inoue H; Mori M
    Int J Oncol; 2011 Aug; 39(2):361-72. PubMed ID: 21617860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
    Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
    Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer.
    Kang MA; Kim JT; Kim JH; Kim SY; Kim YH; Yeom YI; Lee Y; Lee HG
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):761-9. PubMed ID: 19034516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.
    Lan Y; Zhang Y; Wang J; Lin C; Ittmann MM; Wang F
    Int J Cancer; 2008 Aug; 123(3):543-51. PubMed ID: 18498131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma.
    Wang JJ; Fang ZX; Ye HM; You P; Cai MJ; Duan HB; Wang F; Zhang ZY
    Dis Esophagus; 2013; 26(7):729-36. PubMed ID: 23301842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.
    Kita Y; Nishizono Y; Okumura H; Uchikado Y; Sasaki K; Matsumoto M; Setoyama T; Tanoue K; Omoto I; Mori S; Owaki T; Ishigami S; Nakagawa H; Tanaka F; Mimori K; Mori M; Natsugoe S
    Oncol Rep; 2014 May; 31(5):1986-92. PubMed ID: 24604089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
    Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
    Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
    Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
    Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance.
    Wang J; Xu L; Liu Y; Chen J; Jiang H; Yang S; Tan H
    Int J Clin Exp Pathol; 2014; 7(12):8593-601. PubMed ID: 25674223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling.
    Li Z; Xue TQ; Yang C; Wang YL; Zhu XL; Ni CF
    J Cell Biochem; 2018 Dec; 119(12):10327-10337. PubMed ID: 30129142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CKS2 modulates cell-cycle progression of tongue squamous cell carcinoma cells partly via modulating the cellular distribution of DUTPase.
    Gao F; Li C; Zhao X; Xie J; Fang G; Li Y
    J Oral Pathol Med; 2021 Feb; 50(2):175-182. PubMed ID: 33107644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CKS2 Promotes the Growth in Non-Small-Cell Lung Cancer by Downregulating Cyclin-Dependent Kinase Inhibitor.
    Wan Z; Wang L; Yang D; Li P; Liu Q; Wang B
    Pathobiology; 2022; 89(1):13-22. PubMed ID: 34333494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer.
    Jonsson M; Fjeldbo CS; Holm R; Stokke T; Kristensen GB; Lyng H
    Neoplasia; 2019 Apr; 21(4):353-362. PubMed ID: 30856376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.
    Feng J; Hu M; Li Z; Hu G; Han Y; Zhang Y; Zhang M; Ren J
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma.
    Wu Z; Lu B; Li X; Miao W; Li J; Shi Y; Yu W
    Clin Exp Pharmacol Physiol; 2018 May; 45(5):444-451. PubMed ID: 29143362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.
    Lyng H; Brøvig RS; Svendsrud DH; Holm R; Kaalhus O; Knutstad K; Oksefjell H; Sundfør K; Kristensen GB; Stokke T
    BMC Genomics; 2006 Oct; 7():268. PubMed ID: 17054779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods.
    Gao L; Chen G; Liang ZQ; Li JD; Li DM; Tang YL; Tang D; Huang ZG; Chen JH; Luo JY; Zeng JH; Dang YW; Feng ZB
    Pathol Oncol Res; 2022; 28():1610307. PubMed ID: 35693634
    [No Abstract]   [Full Text] [Related]  

  • 20. Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer.
    Chen Q; Fu Y; Liu X; Wang P; Dai S; Zhu F; Liu T; Xu W; Wu J
    Mol Carcinog; 2023 Dec; 62(12):1947-1959. PubMed ID: 37642304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.